ARTICLE / CLIENT ALERT
HHS Issues Guidance on Requirements Under HIPAA for Online Tracking Technologies, Addressing Privacy and Security Concerns Related to Health Information
December 5, 2022
Read time: 10 min
On December 1, 2022, the Office for Civil Rights (OCR) at the US Department of Health and Human Services (HHS) issued a Bulletin on the obligations of covered entities and business associates (regulated entities) under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy, Security, and Breach Notification Rules (HIPAA Rules) when using online tracking technologies, such as cookies, web beacons and pixels. The Bulletin aims to provide further clarity on when identifiable information collected by such tracking technologies may also constitute protected health information (PHI) as defined and interpreted under the HIPAA Rules. In such instances, the Bulletin instructs that the technology vendor may be seen as providing a service to the regulated entity that would, in light of the use and disclosure of PHI, create a direct or downstream business associate relationship. Accordingly, the Bulletin states that the regulated entities would need to enter into a business associate agreement (BAA) with the vendor of the technology (and the vendor would, in turn, become a regulated entity) and meet other requirements under the HIPAA Rules. The Bulletin provides long-awaited guidance to help regulated entities review their positions and procedures concerning tracking technologies to ensure that the trackers they implement either do not collect PHI or meet the prerequisites outlined in the Bulletin.
The Bulletin analyzes the application of the HIPAA Rules to regulated entities’ use of tracking technologies, such as cookies, web beacons and pixels. In particular, the Bulletin addresses the following:
- Tracking on user-authenticated web pages
- Tracking on unauthenticated web pages
- Tracking within mobile apps
- HIPAA compliance obligations for regulated entities when using tracking technologies.
Although the Bulletin suggests that identifiable information collected through a tracking technology deployed on a regulated entity’s website or mobile app is generally going to be considered PHI, it recognizes that there are exceptions to this default rule based on the context in which the information is collected. The dividing line remains gray, but it pivots around an analysis of whether the identifiable information collected by the tracking tool is indicative that the individual has received or will receive health care services or benefits from the covered entity, and thus relates to the individual’s past, present, or future health or healthcare or payment for care. Put another way, if the individual is seen as raising her hand to seek out or obtain information, the individual is signaling an intention to enter into a plan member or patient relationship with the regulated entity that the HIPAA Rules would seek to recognize and then protect.
If a regulated entity can demonstrate that the information collected by the tracker is not indicative that the individual has received, seeks to receive, or will receive healthcare services or benefits, then the information is potentially not PHI. In either case, the information may also be subject to other regulatory regimes. The Bulletin identifies the different contexts where this line of reasoning may be viable and when it is likely not viable.
TRACKING ON USER-AUTHENTICATED WEB PAGES
User-authenticated web pages are areas of a website that require users to log in before they can access the webpage, such as a patient or health plan beneficiary portal or a telehealth platform. OCR reasons that because user-authenticated web pages contain PHI, tracking technologies placed on these pages would in general have access to PHI. OCR, therefore, cautions regulated entities that they should (1) ensure that the disclosure of PHI collected on user-authenticated web pages is permissible (i.e., the vendor is providing a service to the regulated entity) and (2) enter into a BAA with tracking technology vendors that access such PHI. For example, OCR notes that a tracker on an appointment portal might result in the technology vendor automatically receiving information about an individual’s appointment and connecting it with the individual’s IP address. Per the Bulletin, such information would constitute PHI, and a BAA would be required with the tracking technology vendor.
TRACKING ON UNAUTHENTICATED WEB PAGES
The Bulletin distinguishes unauthenticated web pages from user-authenticated web pages, noting that unauthenticated web pages consist of publicly available websites that do not require the user to log in. Importantly, the Bulletin concludes that, unlike user-authenticated web pages, tracking technologies generally do not have access to PHI from users browsing unauthenticated web pages and therefore are not regulated by HIPAA Rules. Even on unauthenticated web pages, OCR warns that regulated entities must be mindful of the type of information that trackers have access to and ensure that no PHI is disclosed. The Bulletin offers two examples of unauthenticated web pages that may disclose PHI to trackers:
Example 1: The Bulletin notes that the login page on a healthcare provider’s patient portal or a user registration webpage, although unauthenticated, may nevertheless collect PHI from individuals. As a result, a tracking technology vendor that collects an individual’s login or registration information via such web pages would need to be a business associate of the regulated entity.
Example 2: The Bulletin notes that unauthenticated web pages that address specific symptoms or health conditions may provide vendors access to PHI in certain circumstances. The Bulletin unfortunately does not elaborate on the certain circumstances under which information collected from the browsing of these web pages would be PHI. It seems based on the initial default rule presented by the Bulletin, however, that if the information collected by the tracker relates to the past, present or future healthcare of the individual or payment for care (e.g., the fact that the user searched for available appointments with the healthcare provider, or that the user visited a page about a specific symptom or health condition in such a way that there is reason to believe the individual is seeking out care for herself or a household member, as opposed to, for example, researching a school paper), OCR may consider such information to be PHI.
This second example may give regulated entities some pause, as it is unclear how detailed the information about an individual’s visit to a webpage addressing symptoms or health conditions would need to be to constitute PHI. Non-patient visitors to a healthcare provider’s website may, for example, seek information about a particular treatment or symptom because they are conducting market research—not because they have a particular symptom or disease. Nevertheless, regulated entities will need to exercise caution and fully vet the information collected by tracking technologies related to diseases and symptoms on their websites. In addition, regulated entities may consider other user experience set-ups to distinguish reasonably between individuals seeking or receiving care and those who are not.
TRACKING WITHIN MOBILE APPS
Mobile apps offered by regulated entities collect various types of information that is considered PHI, including geolocation, device ID and advertising ID. Regulated entities must comply with the HIPAA Rules with respect to this information, including in cases of subsequent disclosures to the mobile app vendor, tracking technology vendor or any other recipient of such information.
Example: OCR suggests that the HIPAA Rules apply to any PHI that a covered health clinic collects through the clinic’s mobile app that patients use to track health-related variables associated with pregnancy (e.g., menstrual cycle, body temperature or contraceptive prescription information).
OCR distinguishes the data collected through mobile apps offered by regulated entities from the data collected through mobile apps offered by non-regulated entities. For the latter, the HIPAA Rules do not protect the privacy and security of information that users voluntarily download or enter into mobile apps not developed or offered by or on behalf of regulated entities. Instead, other rules, such as the Federal Trade Commission (FTC) Act, the FTC’s Health Breach Notification Rule and state consumer privacy laws (like the California Consumer Privacy Act) may apply.
COMPLIANCE OBLIGATIONS WHEN USING TRACKING TECHNOLOGIES
The Bulletin reminds regulated entities that they must follow all HIPAA Rules when using and disclosing PHI to a vendor of tracking technologies. For example:
- Regulated entities should evaluate their relationships with tracking technology vendors to determine whether such vendor meets the definition of a business associate and ensure that the disclosures made to such vendors are permitted by the Privacy Rule. If there is a business associate relationship in place, the vendor must sign a BAA. The Bulletin cautions, however, that signing a BAA does not make a tracking technology vendor a business associate if the tracking technology vendor does not meet the business associate definition.
- A regulated entity must obtain an individual’s HIPAA-compliant authorization before disclosing PHI to a vendor in situations where there is no business associate relationship in place. Privacy notices, website terms or website banners that ask users to accept or reject the website’s use of cookies and other tracking technologies do not constitute a valid HIPAA authorization. When such an authorization is presented, it cannot be presented in such a way that it results in a patient or member’s otherwise access to treatment, payment or healthcare operations becoming conditioned on signing the authorization.
- A regulated entity’s Risk Analysis and Risk Management processes under the Security Rule must address the use of tracking technologies.
- Deidentification of the data by the tracking vendor before it begins processing the data does not absolve the vendor of HIPAA compliance obligations because, according to the Bulletin, the tracking vendor would in that instance receive PHI prior to deidentification. In these circumstances, the regulated entity would need to take steps to either ensure that the vendor is a business associate and agrees to a BAA or take steps to obtain an individual’s HIPAA-compliant authorization.
When tracking technologies collect information that is not considered PHI, regulated entities must still consider whether other privacy laws apply, such as the California Consumer Privacy Act. Starting in 2023, the California Consumer Privacy Act and other US state consumer privacy laws will more strictly regulate the use of cookies—particularly those that involve a “sale” or “sharing” of a user’s personal information. Regulated entities should be mindful of these legal requirements, particularly when the information collected via the cookie could be considered sensitive personal information (e.g., health information) under such laws, requiring the regulated entity to obtain opt-in consent in certain states prior to collecting the data.
The Bulletin does not address how OCR will approach enforcement of these cases, including whether the regulated entity is more at risk because a BAA is not in place and/or the regulated entity should have known that it was sharing PHI with a vendor. This may cause some regulated entities to rethink their strategies when deploying tracking technologies from vendors that do not sign BAAs, are not currently set up to comply with the HIPAA Rules or publicly state that they do not comply with the HIPAA Rules.
Businesses should evaluate their use of online tracking technologies and data sharing with tracking technology vendors. Our Global Data Privacy & Cybersecurity team can help you assess the applicability of this guidance to your business practices and help with your compliance efforts. For assistance, please reach out to your McDermott lawyer or contact any of the authors.

CLOs: Adding Flexibility to Engage in Liability Management Transactions
ARTICLE / CLIENT ALERT
CLOs: Adding Flexibility to Engage in Liability Management Transactions
December 5, 2022
Read time: 8 min
When the supply of capital outweighs demand, as has occurred recently, borrowers have leverage to help them set favourable debt terms. Additionally, fewer arrangers hold loans for their own account than in the past, and therefore they have less of a direct interest in credit document negotiations. As a result, credit terms have loosened over time, allowing distressed borrowers to raise capital on company-friendly terms.
These transactions, commonly referred to as liability management transactions, have often taken the form of “uptiering” financings and “drop down” financings. Although borrowers have engaged in these types of transactions for some time, they have occurred with greater frequency in recent years. This trend may accelerate as economies cool in the face of higher interest rates, inflationary pressures and other headwinds.
CLOs typically require flexibility to participate in (or challenge) liability management and other restructuring transactions to maximize recoveries and preserve the value of their loan positions. This Alert describes these transactions, recent challenges and how CLOs have added flexibility in their terms to allow for participation in liability management transactions.
Uptiering Financings
In an “uptiering” transaction, certain existing lenders to the borrower provide the same borrower with a new senior facility which ranks senior to the existing facility. The new facility frequently consists of an exchange of at least a portion of the debt under the existing facility for debt under the new facility, with an additional loan of new money.
Parties often accomplish these transactions through amendments to the applicable debt and lien baskets under the existing credit documentation with the support of majority lenders only, and without any notice to the minority lenders or any ability for them to participate. Due to the nature of these deals, uptiering transactions have resulted in a wave of litigation from excluded minority lenders.
Minority lenders challenging uptiering transactions have argued primarily that the transaction violates their “sacred rights” under the applicable credit agreement as a form of non-pro rata sharing and an effective waterfall amendment and collateral release (being amendments that would typically require the consent of all lenders). Minority lenders have also argued that these transactions breach the implied covenant of good faith and fair dealing and results from tortious interference with the existing facility.
In response, borrowers and majority lenders have argued that a strict read of the applicable credit documents permits these transactions. Borrowers and majority lenders have often relied on a common exception to most pro rata sharing provisions that accommodates Dutch auctions and “open market” purchases.
Borrowers and majority lenders have also drawn a distinction between lien release (which generally requires consent of all lenders for substantially all the collateral) and lien subordination (which may have the effect of lien release but may not technically require a 100 percent vote under the credit agreement). They have further commonly structured uptiering transactions such that the subordination of the existing facility is accomplished pursuant to an intercreditor agreement (which generally does not require a 100 percent vote) as opposed to amendments to the application of proceeds section in the existing credit agreement (which generally requires the consent of all lenders).
Of five recent (and more robust) opinions issued on this topic, three (Murray Energy, Serta and TPC) have more strictly interpreted the terms of the applicable loan documents, distinguishing between lien subordination on the one hand and collateral release and/or waterfall amendments on the other. The remaining two (Trimark and Boardriders) have allowed the plaintiffs’ claims to proceed. In contrast, courts have generally allowed claims that uptiering transactions do not fall within Dutch auction and open market purchase pro rata sharing exceptions contained in credit agreements to proceed to trial (Murray Energy, Serta, Trimark and Boardriders). Two of those cases, however, have since settled (Murray Energy and Trimark).
Although court decisions on uptiering transactions have varied, there are a few key takeaways:
- To date there has been little guidance on the applicability of the “open market purchase” exception to pro rata sharing protections. The exception is a relatively common one and as such the issue is likely to be the subject of further litigation.
- Lenders should keep in mind that judicial guidance has not been uniform regarding the scope of waterfall rights and protections; as a result, it is unclear whether any given court will adhere strictly to the agreement’s language or take a more holistic approach. Consequently, when reviewing or negotiating credit agreements, prospective lenders should focus on the level of voting that is needed to subordinate liens, amend waterfall and pro rata sharing provisions, and whether the credit agreement provides for “open market purchase” and other exceptions to pro rata sharing.
- Credit agreements that expressly require affected lender consent (including for entry into any new intercreditor agreement) to subordinate liens and rights to receive payment and do not contain or limit “open market purchase” provisions likely best protect minority lender rights.
Drop Down Financings
Drop-down transactions involve the transfer of assets from inside to outside an existing security package to collateralize new structurally senior financing. Borrowers can combine drop-downs with a non-pro rata partial roll up of existing loans relying on the open market purchase exceptions discussed above to maximize liquidity. Notable drop down transactions include J.Crew, PetSmart, Neiman Marcus, Travelport and Envision Health.
In a typical drop down transaction, the borrower will first form or designate an unrestricted subsidiary. Next it will stack covenant baskets to sell, contribute or transfer assets to the unrestricted subsidiary causing a release of the liens of the existing lenders on the assets. Then, the unrestricted subsidiary will incur new financing that is secured by a first priority lien on the transferred assets such that it is structurally senior to the existing debt. Litigation may then ensue typically focused on the value of the assets transferred and whether there was sufficient basket capacity under the existing credit agreement to accomplish the transfers.
To reduce the possibility of drop-down transactions, lenders should take a close look at and try to limit provisions that permit leakage, such as investment baskets that allow loan obligors to invest in non-loan party restricted subsidiaries and “trap doors” that then permit those non-loan party restricted subsidiaries to invest in unrestricted subsidiaries, essentially converting investment capacity into restricted payment capacity. Recently some counter-provisions have emerged, such as increasing restrictions on the transfer of specified material assets (often Intellectual Property), closing investment loopholes and providing greater limitations on the actions of, and transactions with, unrestricted subsidiaries and other non-loan parties.
CLOs’ Treatment of Uptiering and Drop Down Transactions
These issues affect CLOs that are members of loan syndicates in two ways: First, can CLOs invest in uptiering and/or drop-down transactions or subsequent restructuring paper; and second, can CLOs bring a claim if they are part of a minority group of lenders that suffer from subordination and a reduction in value. The terms of the CLO documentation are crucial to any investment, as the terms will have to allow for sufficient flexibility to participate. If a CLO proposes to challenge a liability management transaction, then the terms of the underlying collateral loan documentation and the applicability of the court decisions discussed above will be most pertinent.
Relatively recent additions to CLO documentation have addressed liability management transactions in various ways, including by adding Collateral Enhancement Obligations, Bankruptcy Exchanges, Corporate Rescue Loans, Restructured Obligations and Loss Mitigation Obligations.
More recently, CLO documents have addressed uptiering transactions. Typically, if a borrower takes out new money financing which is senior to the original debt, or current creditors of the borrower have the option to exchange their existing debt for new senior debt, then the CLO should be able to participate in this new financing or exchange. The CLO will treat the new asset as a performing asset if it satisfies the eligibility criteria, subject to certain carveouts — for example for rating and maturity date requirements, and concentration limits. This “Uptier Priming Debt” concept overlaps somewhat with other distressed debt concepts used in CLOs. Therefore, CLOs should take care as to the treatment and demarcation of this debt within the CLO documentation as it potentially falls within more than one definition with different resulting consequences.
Authored by Phillip J. Azzollini, Douglas S. Mintz, Daniel V. Oshinsky, Ned S. Schodek, Martin Sharkey and Craig Stein.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
This communication is issued by Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

Commerce Issues Preliminary Determination in Solar Circumvention Investigation but Leaves Important Questions Unanswered
ARTICLE / CLIENT ALERT
Commerce Issues Preliminary Determination in Solar Circumvention Investigation but Leaves Important Questions Unanswered
December 2, 2022
Read time: 9 min
On December 1, 2022, the US Department of Commerce (Commerce) published its preliminary determination in the circumvention investigation into whether imports of crystalline silicon photovoltaic (CSPV) cells or modules imported from Cambodia, Malaysia, Thailand or Vietnam (collectively, the target countries) are circumventing antidumping duty (AD) and countervailing duty (CVD) orders on CSPV cells or modules from China.[1] Commerce found that all four target countries were circumventing the Orders, but five companies were found not to be circumventing (though Commerce is currently only applying its non-circumventing finding to one of those companies). Additionally, all companies in the target countries may certify that they qualify for the tariff moratorium on CSPV cells and modules; however, Commerce did not provide any clarity on the meaning of the term “utilize” or “utilization” as used in its regulations. Key takeaways from Commerce’s preliminary determination include the following:
- Commerce found, on a countrywide basis, that CSPV cells and modules from all four target countries are circumventing the Orders.
- Commerce established three certification regimes: One for certifying that the entries qualify for the tariff moratorium announced in Presidential Proclamation 10414[2] and established in 19 C.F.R. Pt. 362; a second for certifying that CSPV cells and modules exported from the target countries (inquiry merchandise) were manufactured by a company found not to be circumventing; and a third for companies to certify that entries are not inquiry merchandise based on the components used to produce the merchandise.
- Several companies were found to be noncompliant in Commerce’s investigation. As a result, those companies cannot participate in the second or third certification regimes discussed above. Those companies may still participate in the first certification regime and qualify for the tariff moratorium.
- Commerce established a process for exporters/producers in the target countries and/or US importers to request the rate of the Chinese affiliate of the exporter/producer in the target country or the Chinese wafer supplier (if any).
SCOPE OF THE CIRCUMVENTION INVESTIGATION
In its preliminary determination, Commerce provided the following description of the scope of merchandise subject to the investigation:
This circumvention inquiry covers: (A) crystalline silicon photovoltaic cells that meet the physical description of crystalline silicon photovoltaic cells in the scope of the underlying AD/CVD orders, subject to the exclusions therein, whether or not partially or fully assembled into other products, that were produced in [the target county] from wafers produced in China; and (B) modules, laminates, and panels consisting of crystalline silicon photovoltaic cells, subject to the exclusions for certain panels in the scope of the underlying orders, whether or not partially or fully assembled into other products, that were produced in [the target country] from wafers produced in China and where more than two of the following components in the module/laminate/panel were produced in China: (1) silver paste; (2) aluminum frames (3) glass; (4) backsheets; (5) ethylene vinyl acetate sheets; and (6) junction boxes. If modules, laminates, and panels consisting of crystalline silicon photovoltaic cells do not meet both of the conditions in item (B) above, then this circumvention inquiry does not cover the modules, laminates, and panels, or the crystalline silicon photovoltaic cells within the modules, laminates, and panels, even if those crystalline silicon photovoltaic cells were produced in [the target country] from wafers produced in China. Wafers produced outside of China with polysilicon sourced from China are not considered to be wafers produced in China for purposes of this circumvention inquiry.[3]
This scope and the certification regime provide some clarity but do not clearly establish how Commerce will treat CSPV cells or modules that are produced in a target country but further processed in a non-target country before being exported to the United States.
COMPANIES FOUND NOT TO BE CIRCUMVENTING
While certain mandatory respondents in Cambodia, Malaysia and Vietnam were preliminarily found not to be circumventing, Commerce still found—on a countrywide basis—that exporters/producers of CSPV cells and modules from those countries are circumventing. Additionally, with the exception of one company, Commerce cannot implement its non-circumvention finding until the mandatory respondents provide the names of their Chinese wafer suppliers for the public record.
For the Cambodian and Malaysian companies that were not found circumventing, Commerce could not “implement [its] preliminary finding” of non-circumvention with respect to these companies “because [the companies] ha[d] not disclosed for the public record the names of [their] [wafer] exporters in China.”[4] If or when the companies disclose the names of their wafer exporters in China for the public record, Commerce will notify US Customs and Border Protection (CBP) that the companies’ exports of inquiry merchandise are excluded from the preliminary countrywide affirmative finding of circumvention in Malaysia or Cambodia, respectively. With respect to the one exception company, Commerce preliminarily found that its “exports of inquiry merchandise produced with wafers exported by the specific companies reported in its questionnaire responses are not subject to this preliminary finding.”[5]
COMMERCE’S USE OF ADVERSE FACTS AVAILABLE FOR CERTAIN COMPANIES
Commerce found that certain companies did not comply with its circumvention investigation to the best of their ability. Thus, while those companies will have the ability to certify that they qualify for the tariff moratorium (see below), they cannot participate in the certification process to establish whether they are circumventing the Orders. As a result, these companies will not be eligible to certify that their entries are outside the scope of the circumvention investigation.
THE CERTIFICATION PROCESS
In the preliminary determination, Commerce established three certification processes with which importers and exporters must comply: (1) to establish whether the imported merchandise qualify for the moratorium on imports established by Presidential Proclamation 10414 and 19 C.F.R. Pt. 362; (2) to establish whether the entries were produced by a company found not to be circumventing; and (3) to establish whether the entries are inquiry merchandise (i.e., in-scope) based on the inputs used in producing the entries.
Moratorium (Or Applicable Entries) Certification
Commerce established a certification process by which importers and exporters can qualify for the tariff moratorium. This requires the importer and exporter to certify that the merchandise was produced in one of the target countries and exported to the United States “without further assembly in another country.”[6] The importer must also certify that: (1) the merchandise was withdrawn from a CBP warehouse before June 6, 2024 (or before the date when the emergency described in Proclamation 10414 is terminated, if it is terminated early); and (2) that, for merchandise withdrawn from a CBP warehouse after November 15, 2022, the merchandise (cell or module) will be utilized in the “United States by no later than 180 days after the earlier of [June 6, 2024], or the date the emergency described in Presidential Proclamation 10414 is terminated.”[7] Claims made in this certification “are subject to verification by CBP and/or Commerce.”
Certification for Non-Circumventing Companies
There are special certifications for the one exception company as it was found not to be circumventing.[8] If the other companies that were found not to be circumventing provide the names of their Chinese wafer suppliers for the public record, Commerce will likely allow those companies to use the same type of certifications to establish that their entries are not subject to the circumvention finding.[9]
Certifying That Entries Are Out-of-Scope
Commerce also established a certification process through which importers and exporters can certify that the imported entries do not contain inputs so as to be in-scope of the circumvention investigation.
For Cells
If the imported merchandise is a CSPV cell that is not incorporated into a CSPV module, laminate, or panel, then the importer and exporter must certify that the wafers were not supplied from a Chinese company to certify out of the circumvention finding.[10]
For Modules
If the merchandise is or contains a CSPV module, laminate, or panel, then, to certify that the merchandise is outside the scope of the circumvention investigation, the importer and exporter must certify either that:
-
The wafers were not supplied by a Chinese company; or
-
The wafers were supplied by a Chinese company, but no more than two of the following inputs (which were used to manufacture the CSPV module) were produced in China:
-
Silver Paste
-
Aluminum Frames
-
Glass
-
Backsheets
-
Ethylene-Vinyl Acetate
-
Junction Boxes[11]
-
ESTABLISHING RATES
If merchandise is subject to the circumvention finding, then Commerce explained two ways (depending on the circumstances) how the rate for the inquiry merchandise may be determined.
First, if the exporter/producer in the target country has a Chinese affiliate or used Chinese wafers to manufacture the CSPV cell or module, and the Chinese affiliate or Chinese wafer supplier (as the case may be) has a rate in the AD/CVD proceedings on the Orders, then Commerce will apply that Chinese affiliate’s or Chines wafer suppliers’ rate.
To receive the rate of the Chinese wafer supplier, the exporter/producer in the target country or the importer of record in the United States “may file a request in ACCESS on the record of the applicable proceeding segment that Commerce establish a case number in ACE for the Orders for the applicable third-country that is specific to the Chinese wafer exporter. CBP may also submit such a request to Commerce through the ACE AD/CVD Portal Inquiry System.”[12]
Second, if the exporter/producer in the target country does not have a Chinese affiliate and used Chinese wafers to manufacture the CSPV cell or module, and the Chinese wafer supplier does not have a rate in the AD/CVD proceedings on the Orders, then Commerce will use the China-wide rate in the underlying AD proceeding (238.95%) and the all-others rate from the CVD proceedings (15.24%) for a total rate of up to 254.19%.
ISSUES THAT REMAIN UNCLEAR
Commerce did not provide any additional guidance on the meaning of the term “utilized” or “utilization” as used in 19 C.F.R. § 362.102. However, the certification regime indicates one potential avenue that Commerce may use to enforce the utilization requirement: Representations that CSPV cells and modules will be utilized within 180 days of the termination of the emergency described in Proclamation 10414 are subject to verification by Commerce or CBP.[13]

Key Takeaways | Guidance on the Wage and Apprenticeship Provisions
ARTICLE / OTHER
Key Takeaways | Guidance on the Wage and Apprenticeship Provisions
December 2, 2022
Read time: 3 min
The Navigating the New Energy Landscape webinar series came back last week for a special bonus session that focused on the just-released Internal Revenue Service (IRS) guidance on the wage and apprenticeship provisions included in the Inflation Reduction Act of 2022 (IRA).
During this webinar, McDermott Partners Heather Cooper and Philip Tingle walk through the new guidance, covering key issues and drilling down into the impact of the 60-day countdown clock for which developers have to implement these provisions or face the loss of critical tax benefits for their renewable energy projects.
Below are key takeaways from the discussion:
- IRS Notice 2022-61 provides additional guidance on the prevailing wage and apprenticeship requirements included in the IRA, which apply to a broad range of energy tax credits. Projects that do not meet these requirements potentially face an 80% reduction to any applicable energy tax credits. However, due to the 60-day delay between the release of the guidance and when the rules take effect, projects that begin construction before January 30, 2023, will not be subject to the requirements.
- Notice 2022-61 also provides clarification (largely by reference) to existing US Department of Labor (DOL) regulations and prior IRS guidance. For example, it clarified that the existing IRS framework for determining the beginning of construction will be preserved. Other developments include a contemporaneous recordkeeping requirement necessary to establish compliance with the prevailing wage and apprenticeship requirements, clarification on the good faith effort exception to the apprenticeship requirements, and a new DOL email address for questions regarding prevailing wage determinations.
- Despite this guidance, many questions remain unanswered. While many key definitions and rules are clarified by reference to DOL rules, this has not eliminated uncertainty regarding their implementation. McDermott’s energy & project finance team is working closely with the Firm’s employment team to tap into their vast experience with the DOL.
- These developments raise many new considerations for developers. Those that can start construction before January 30 may wish to determine how to meet the beginning of construction requirements promptly and effectively before the guidance takes effect. Those that cannot start construction before January 30 will need to consider how to manage potential risks that may arise from the new rules. This could require additional transactional scrutiny when drafting and negotiating around compliance.
To access past webinars in the Navigating the New Energy Landscape series and to begin receiving Energy updates, including invitations to the webinar series, please click here.

From January 1, 2023, Landlords Must Share CO2 Costs
ARTICLE / CLIENT ALERT
From January 1, 2023, Landlords Must Share CO2 Costs
December 2, 2022
Read time: 2 min
Düsseldorf, December 1, 2022 – On Friday, November 25, 2022, the Bundesrat approved the “Law on the Allocation of Carbon Dioxide Costs” (CO2KostAufG), which had already been passed by the Bundestag. Under the new law, as of January 1, 2023, landlords of commercial premises will in principle have to bear 50 percent of the carbon dioxide costs incurred for the heating and hot water supply of the rental property themselves and will not be able to pass these on to their tenants in full, as was previously the case. The following article presents the main new provisions of the law with regard to commercial properties.

Year in Review | The Wild Ride That Was Crypto and FinTech in 2022
ARTICLE
Year in Review | The Wild Ride That Was Crypto and FinTech in 2022
December 1, 2022
Read time: 3 min
TAKEAWAYS
The session focused on the wild ride that was crypto and FinTech in 2022. We were joined by guest speakers Andria van der Merwe, executive vice president at Compass Lexecon, and Katherine Kirkpatrick, general counsel at Maple Finance, as well as McDermott Partners Andrea Kramer and Alexandra Scheibe and Associates Daley Epstein and Rachel Rosen, all of whom offered their insights and analysis of the major crypto events that occurred this past year.
From “crypto winter” to the news surrounding FTX, recent events have left many in the community wondering what lies ahead for the crypto industry. The group resoundingly agreed that the challenges that arose this year are all part of the industry’s broader maturation. After all, previous dramatic downturns in crypto have been followed by explosive growth and innovation. If 2022 has taught us anything, it’s that carefully crafted regulation is needed for this growing but still nascent industry.
Notable topics discussed during the session included: tax considerations when reporting crypto losses, lessons learned from recent crypto platform bankruptcy filings, the future of DeFi, and litigation and regulatory updates and forecasting. We look forward to meeting again in 2023!
From “crypto winter” to the news surrounding FTX, recent events have left many in the community wondering what lies ahead for the crypto industry. The group resoundingly agreed that the challenges that arose this year are all part of the industry’s broader maturation. After all, previous dramatic downturns in crypto have been followed by explosive growth and innovation. If 2022 has taught us anything, it’s that carefully crafted regulation is needed for this growing but still nascent industry.
Notable topics discussed during the session included: tax considerations when reporting crypto losses, lessons learned from recent crypto platform bankruptcy filings, the future of DeFi, and litigation and regulatory updates and forecasting. We look forward to meeting again in 2023!

A Tsunami of Lawsuits Is Expected to Slam Institutions in the Wake of New York Adult Survivors Act
ARTICLE / CLIENT ALERT
A Tsunami of Lawsuits Is Expected to Slam Institutions in the Wake of New York Adult Survivors Act
December 1, 2022
Read time: 4 min
A new revival window opened on Thanksgiving Day for filing sexual assault and abuse lawsuits that would otherwise be time-barred by the New York statute of limitations. This means that entities who formerly employed or were connected to alleged sexual offenders may now have to respond to related claims of negligence and intentional misconduct lodged against them concerning events that may have occurred decades ago.
The Adult Survivors Act (ASA), codified as CPLR § 214-j, is a New York state law that creates a one-year “lookback window” for expired civil claims to be filed based on conduct that constitutes a sexual offense, as defined in Article 130 of the New York Penal Law, that was committed against individuals who were 18 years of age or older at the time of the sexual offense. The ASA expires on November 23, 2023, which means the window to file claims closes on that date.
Under the ASA, survivors of sexual offenses can bring claims against individual offenders in addition to bringing related claims against public and private institutions, companies and other organizations that may have employed the alleged offenders or otherwise been connected to such offenders. The nature and extent of the relationships between the alleged offenders and entities will be hotly contested issues litigated in these actions. Plaintiffs will no doubt bring claims based on intentional and negligent acts and omissions, alleging, for example, that entities: failed to protect plaintiffs from sexual offenders; were negligent in implementing proper safety protocols; were negligent in hiring, retaining, supervising and directing offenders; were negligent in implementing proper safety and reporting protocols; and were liable for infliction of emotional distress.
Key issues in these litigations may involve the duty, if any, that entities owed to plaintiffs, the extent of entities’ control of alleged offenders, whether alleged offenders acted as agents of entities affiliated with them and whether these entities had actual or constructive knowledge of an alleged offender’s sexual offenses committed against a plaintiff or a propensity to commit sexual offenses based on past conduct.
But for the ASA, many adult survivors of sexual offenses would not have any legal recourse available to them as the time to bring their claims in court has long expired. Individuals have started—and are expected to continue—to file civil lawsuits during this one-year window against alleged offenders and entities in a wide range of industries (e.g., finance, technology, healthcare, academia, entertainment and sports). These matters are often high profile and high stakes, presenting significant reputational risks to the sued entities.
The ASA mirrors New York’s Child Victims Act (CVA) which created a two-year “lookback window” for child sexual abuse survivors (i.e., those under 18 years of age at the time of the alleged abuse) to file civil lawsuits. The CVA’s window closed on August 14, 2021, and resulted in the filing of nearly 11,000 suits.
McDermott has an experienced team of lawyers who specialize in helping clients navigate sexual assault and abuse investigations and litigations, including former prosecutors who were trained to handle these types of matters.
For more information and resources, please contact Greer Griffith, Lisa A. Linsky, Kelly Shami or Max Kellogg.
News on Deduction Taxes for Intangible Assets
ARTICLE
News on Deduction Taxes for Intangible Assets
1. December 2022
Read time: 2 min
Dr. Gero Burwitz authored the article “News on deduction taxes for intangible assets”, featured in Neue Zeitschrift für Gesellschaftsrecht (NZG), p. 1575 et seq. in December, 2022.

IRS Issues New Procedures for Large Corporate Audit Disclosures
ARTICLE / CLIENT ALERT
IRS Issues New Procedures for Large Corporate Audit Disclosures
November 30, 2022
Read time: 8 min
For decades, large corporate taxpayers under continuous audit have been able to make disclosures under Revenue Procedure 94-69 at the beginning of an examination to notify the Internal Revenue Service (IRS) of adjustments (both positive and negative) to their tax returns and thereby obtain protection from various penalties and obviate the need to file a formal amended tax return. In 2020, the IRS questioned the continuing utility of this disclosure process and invited comments on said process. With the new Revenue Procedure 2022-39, the IRS has moved the largest corporate taxpayers into a new era of voluntary disclosure. This is a significant development for impacted taxpayers.
WHERE WE WERE
Revenue Procedure 94-69 applied to taxpayers subject to the IRS’s Coordinated Examination Program (CEP)—essentially large corporate taxpayers under continuous IRS examination. The idea was to permit taxpayers to provide a written statement to the IRS at the beginning of an examination “of all items that would result in adjustments if the taxpayer, in lieu of furnishing a written statement, filed a properly completed amended return.” This statement would act as a “qualified amended return”; no formal return or IRS form is required to effectuate the disclosure. The result of making the voluntary disclosure was the avoidance of IRC Section 6662(b)(1) and (2) penalties premised on negligence, the disregard of tax rules and regulations and a substantial understatement of income. The statement could also act as an “adequate disclosure” made on Forms 8275 and 8275-R, as appropriate.
The standard practice of eligible taxpayers was not only to disclose adjustments that would be subject to additional tax, but also to disclose affirmative claims that would be incorporated into the final examination report. This was an extremely useful tool for busy tax departments to avoid having to prepare a formal amended return for affirmative changes to items of income, deduction and credit. And from all appearances and reports, the practice worked extremely well for both taxpayers and IRS examination teams.
In 2000, the IRS eliminated the CEP and introduced the Coordinated Industry Case (CIC) Program. The IRS extended the use of Revenue Procedure 94-69 to CIC taxpayers.
In May 2019, the IRS replaced the CIC Program with the Large Corporate Compliance (LCC) Program, effective for audits of tax years 2017 and later. Unlike the CEP and CIC Program, the LCC Program is not a continuous examination program but rather employs automatic application of data analytics to determine those corporate taxpayers that pose the highest compliance risk.
With scant resources and a shift from a continuous IRS audit paradigm of the nation’s largest taxpayers, the technical foundation upon which Revenue Procedure 94-69 was based became unsteady. The IRS therefore announced that, as a transition from the CEP to the CIC Program, Revenue Procedure 94-69 would continue to apply to any taxpayer that is in both the CIC Program (for years prior to 2017) and the new LCC Program (for the 2017 tax year). However, the procedure would not apply to taxpayers who were not historical CIC taxpayers.
Because of the popularity of the practice, in August 2020, the IRS solicited comments from taxpayers and tax professionals about what to do. After receiving substantial comments, the IRS has now issued Revenue Procedure 2022-39 to replace Revenue Procedure 94-69.
WHERE WE ARE NOW
Revenue Procedure 2022-39 provides new procedures for taxpayers to file a qualified amended return and to avoid certain civil tax penalties by disclosing errors and omissions that were not known at the time of filing the return.
Who Is Eligible?
Taxpayers are selected for examination under the LCC Program or the Large Partnership Compliance Program (LPC) (or a successor program) if, on the date on which the IRS first contacts the taxpayer concerning an examination, at least four of the taxpayer’s income tax returns for the five taxable years preceding the taxable year at issue are (or were) under examination under the LCC Program, the CIC Program, the LPC or a successor program. Ineligible taxpayers must follow the qualified amended return rules set forth in Treasury Regulation § 1.6664-2(c)(3).
How to Make a Disclosure?
To avoid the imposition of a civil tax penalty for negligence or disregard of rules or regulations and the substantial understatement penalty under IRC Section 6662(b), the eligible taxpayer must complete Form 15307, Post-Filing Disclosure for Specified Large Business Taxpayers (or a successor form), and provide it to the IRS personnel conducting the examination no later than 30 days from the date when the IRS notifies the taxpayer to provide the form or another date agreed to in writing with the IRS.
The description of the item disclosed to the IRS is considered adequate if it consists of information that reasonably informs the IRS of the identity of the item, its amount and the nature of the controversy or potential controversy. Each disclosed adjustment must be stated separately, and no netting of adjustments is allowed. The taxpayer does not need to provide the IRS with a recomputation of the tax for the adjusted and disclosed item unless the item relates to tax credits. The taxpayer may also disclose information for purposes of establishing the reasonable basis of a position.
Form 15307 requires the disclosure of certain specific information. The taxpayer must identify whether it filed a Schedule UTP, Uncertain Tax Position Return Statement, Form 8275 or Form 8275-R with its original return. Some of the required information includes:
- Adjustment Type—ordinary income, capital gain/loss, IRC Section 1231 gain/loss, ordinary gain/loss dividends received deduction, expense deduction, tax credits or other type
- Timing—permanent, temporary, temporary (one to three years), temporary (three to 10 years) or other timing
- Effect on Other Years
- Page and Line on the Tax Return
- Increase or Decrease to Taxable Income
- Increase or Decrease to Tax Credits.
Form 15307 provides three examples of acceptable disclosures and two examples of unacceptable disclosures. Additionally, relevant supporting documentation should be provided for disclosures made on the form. The form must be signed under penalties of perjury.
The Result of Disclosure
Any amounts of additional tax with respect to an item disclosed on Form 15307 will be treated as an amount shown on a qualified amended return. As such, the IRS will not assert a penalty pursuant to IRC Sections 6662(b)(1) and (2). Any additional tax resulting from the disclosure will be subject to the deficiency procedures in IRC Sections 6212 and 6213 or the partnership audit provisions in IRC Section 6221 through 6241.
Failure to provide complete information in accordance with the form’s instructions will not provide penalty protection. The IRS will inform a taxpayer if it determines that a disclosure is inadequate.
Interestingly, Revenue Procedure 2022-39 does not mention the ability of taxpayers to make favorable tax adjustments by virtue of the IRS’s new procedure. However, it is clear from the face of Form 15307 (and the examples in the instructions) that taxpayers can make adjustments that reduce income tax. This is consistent with IRS Publication 5125, which provides that taxpayers subject to examination by the Large Business and International Division may make informal claims for refund to their exam team within 30 calendar days of the opening conference so long as such claims satisfy the standards of Treasury Regulation § 301.6402-2. The instructions to Form 15307 reference these two sources when stating that relevant supporting documents for disclosures should be provided. This indicates that a favorable disclosure, so long as it contains the information sufficient to satisfy the regulation, will operate as an informal claim for refund. This is a huge benefit to taxpayers as it sanctions the making of favorable adjustments without the need to file a formal amended tax return.
When Is Revenue Procedure 2022-39 Effective?
Eligible taxpayers can begin using the new disclosure procedure for examinations that began after November 16, 2022.
Practice Points: We have been reporting on the demise of Revenue Procedure 94-69 for quite some time. Taxpayers have appreciated the ability to adjust their return positions without the inconvenience and expense of filing a formal amended return. And over the years, the practice morphed into the disclosure of both affirmative adjustments (that decreased tax liability) and negative adjustments (that increased tax liability).
New Revenue Procedure 2022-39 changes the landscape for disclosures at the beginning of an examination. Taxpayers and practitioners need to be aware of these changes and ensure they fully and accurately disclose on Form 15307 to obtain the protections afforded by a qualified amended return. Additionally, taxpayers wishing to make favorable tax adjustments on Form 15307 should take care to ensure that disclosures contain sufficient information to constitute a refund claim under existing guidance.

CSRD Update: Corporate Sustainability Reporting Directive (CSRD) adopted
ARTICLE / CLIENT ALERT
CSRD Update: Corporate Sustainability Reporting Directive (CSRD) adopted
November 30, 2022
Read time: 6 min
In November 2022, the Corporate Sustainability Reporting Directive (CSRD) was adopted by the EU Parliament (Parliament) and approved by the European Council (EC). It has thus taken the last hurdle in the legislative process after the European Commission (Commission) published its first proposal for it in April 2021. The CSRD will replace the previously applicable Nonfinancial Reporting Directive (NFRD).
1. Timeline of legislative process
The original CSRD proposal by the Commission was published on April 21, 2021, and was open for debate in a consultation on this legislative process until July 14, 2021. A draft report with proposed amendments was published on November 16, 2021, and the EC draft amendment on February 24, 2022. On June 21, 2022, the EC and the Parliament reached a preliminary political agreement, the draft of which provided for amendments to the Commission’s draft. This draft was adopted by a large majority in the Parliament on November 10, 2022 and approved by the EC on November 28, 2022. The CSRD will now be signed by the President of the Parliament and the President of the EC. Subsequently it will be published in the EU Official Journal and enter into force 20 days after publication. The CSRD must be transposed into the national laws of the EU Member States within 18 months.
According to the original timetable of the Commission’s 2021 draft, the regulations were supposed to apply from January 1, 2024, for fiscal year 2023. However, the CSRD now provides for a later introduction in the form of a phased model (cf. no. 2, please see pdf). This gives companies with the duty to report more time to prepare.
2. Companies covered by the directive
The Proposal significantly expands the group of companies subject to reporting requirements. Subsequently, the following companies will be covered by the CSRD:
- As of January 1, 2024, all EU companies which are already subject to the NFRD and non-EU companies listed on a regulated market in the EU within the definition of large companies with more than 500 employees will be covered.
- As of January 1, 2025, all EU companies regardless of capital market orientation, that exceed two of the following three size criteria (large companies):
i 250 employees on an annual average;
ii balance sheet total of more than 20 million euros;
iii revenue of more than 40 million euros;as well as all large non-EU companies listed on a regulated market in the EU will be covered. - As of January 1, 2026, all listed small and medium-sized companies (SMEs), including non-EU companies listed on a regulated market in the EU, with the exception of micro-companies will be covered as well. According to Directive 2013/34/EU, companies are considered small if they exceed two of the three characteristics (i) 10 employees, (ii) 350,000 euros balance sheet total and (iii) 700,000 euros net revenue. Moreover, small and non-complex credit institutions and captive insurance undertakings will be covered from then on.
- As of January 1, 2028, non-EU companies with
i an annual net revenue at the consolidated or individual level in the EU of more than 150 million euros for each of the last two consecutive financial years, and;
ii at least one subsidiary (which is either a large EU company or an SME) or a branch in the EU that generated an annual net revenue in excess of 40 millions euros in the proceeding financial year
will also be covered.
Reporting at group level will still exempt the subsidiaries from their own reporting obligations, as long as the subsidiary refers to the group report. Large capital market-oriented subsidiaries are exempted from this exemption.
3. Reporting obligations
According to the CSRD, a statement containing all information necessary for an understanding of the company’s business performance, results, position and the impact of its activities will be required. In particular, this statement shall provide information regarding its sustainability strategy and environmental, social and governance issues, such as a description of (i) the company’s business model and strategy in relation to sustainability aspects, (ii) its sustainability objectives, (iii) the role of the administrative, management and supervisory bodies in relation to sustainability issues, (iv) its sustainability policy implemented in relation to sustainability aspects, (v) the due diligence process implemented with regard to sustainability issues as well as the main actual or potential adverse impacts (Principal Adverse Impacts) related to the company’s value chain plus an indication of the measures taken and the outcome of those measures to prevent any actual or potential adverse impacts, and (vi) the main risks to which the company is exposed in relation to sustainability issues.
Moreover, the initial proposal appointed the European Financial Reporting Advisory Group (EFRAG) as the technical advisor to the Commission responsible for developing the European Sustainability Reporting Standards (ESRS). The first set of ESRS was approved by EFRAG on November 15, 2022 and then delivered to the Commission. It consists of twelve intersectoral standards. The Commission now has to adopt the ESRS drafts or revise them itself before they are to be applied as a delegated act by companies in the scope of the CSRD.
4. Mandatory Inclusion in Management Report
Furthermore, according to the CSRD, organizations will no longer be able to choose where they publish the information. In the future, the required information is to be included in the management report.
5. Publication
Publication is to take place in a machine-readable format. The “Single Electronic Reporting Format” will require tagging of sustainability information in the future and is intended to establish compatibility with the “European Single Access Point” yet to be developed by the EU, a central register for digitally prepared reports.
6. Audit and Penalties
There will be an obligation for external verification of the sustainability information – initially with limited assurance. If a company that is required to report under the CSRD does not comply with the obligation to publish the information, the CSRD sets minimum penalty types and process requirements in the penalty investigation, but does not contain a paragraph on uniform penalties, i.e., penalties for violations are left to be determined by the member states.
7. Legislative Process Information
The status of the legislative process of the CSRD can be monitored on the EU legislative observatory.
8. Action Required
The timetable states reporting obligations. To meet this reporting obligations, the affected companies must start collecting the relevant data in the previous year. E.g., a company that must report after January 1, 2025, must set up a process to collect the relevant data starting January 1, 2024. For this companies 2023 is a good year to start setting up the relevant processes.
